Nakashima A - Search Results

1

Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice.

Nagai T, Doi S, Nakashima A, Irifuku T, Sasaki K, Ueno T, Masaki T. Nagai T, et al. Among authors: nakashima a. PLoS One. 2016 Aug 11;11(8):e0160993. doi: 10.1371/journal.pone.0160993. eCollection 2016. PLoS One. 2016. PMID: 27513960 Free PMC article.

2

Radial bone mineral density in hemodialysis patients with adynamic bone disease.

Nakashima A, Yorioka N, Doi S, Ueda C, Usui K, Shigemoto K, Harada S. Nakashima A, et al. Int J Artif Organs. 2003 Mar;26(3):200-4. doi: 10.1177/039139880302600304. Int J Artif Organs. 2003. PMID: 12703885

3

Different risk factors for the maximum and the mean carotid intima-media thickness in hemodialysis patients.

Nakashima A, Yorioka N, Asakimori Y, Ito T, Masaki T, Shigemoto K, Harada S. Nakashima A, et al. Intern Med. 2003 Nov;42(11):1095-9. doi: 10.2169/internalmedicine.42.1095. Intern Med. 2003. PMID: 14686748 Free article.

4

Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.

Nakashima A, Yorioka N, Doi S, Masaki T, Ito T, Harada S. Nakashima A, et al. Bone. 2004 Mar;34(3):579-83. doi: 10.1016/j.bone.2003.11.016. Bone. 2004. PMID: 15003806

5

HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.

Nakashima A, Nakashima R, Ito T, Masaki T, Yorioka N. Nakashima A, et al. Among authors: nakashima r. Diabet Med. 2004 Sep;21(9):1020-4. doi: 10.1111/j.1464-5491.2004.01292.x. Diabet Med. 2004. PMID: 15317608

6

Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.

Nakashima A, Yorioka N, Mizutani T, Yamagata Z, Ueno T, Takasugi N. Nakashima A, et al. Nephron Clin Pract. 2005;99(3):c78-85. doi: 10.1159/000083418. Epub 2005 Jan 19. Nephron Clin Pract. 2005. PMID: 15665550

7

Osteoprotegerin and bone mineral density in hemodialysis patients.

Nakashima A, Yorioka N, Doi S, Takasugi N, Shigemoto K, Kohno N. Nakashima A, et al. Osteoporos Int. 2006;17(6):841-6. doi: 10.1007/s00198-005-0047-0. Epub 2006 Apr 7. Osteoporos Int. 2006. PMID: 16604298

8

Performance of polysulfone membrane dialyzers and dialysate flow pattern.

Nakashima A, Ogata S, Doi S, Yamahira M, Naraki S, Takasugi N, Ohmoto T, Ito T, Masaki T, Yorioka N. Nakashima A, et al. Clin Exp Nephrol. 2006 Sep;10(3):210-5. doi: 10.1007/s10157-006-0431-x. Clin Exp Nephrol. 2006. PMID: 17009079

9

Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.

Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N. Doi S, et al. Among authors: nakashima a. Transplantation. 2007 Jul 27;84(2):207-13. doi: 10.1097/01.tp.0000269614.21367.3f. Transplantation. 2007. PMID: 17667812

10

Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.

Takahashi S, Taniguchi Y, Nakashima A, Arakawa T, Kawai T, Doi S, Ito T, Masaki T, Kohno N, Yorioka N. Takahashi S, et al. Among authors: nakashima a. Nephron Exp Nephrol. 2009;112(2):e59-69. doi: 10.1159/000213896. Epub 2009 Apr 23. Nephron Exp Nephrol. 2009. PMID: 19390220 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

994 results

Search Page

Filters